GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » International Stem Cell Corp (OTCPK:ISCO) » Definitions » Price-to-Free-Cash-Flow

ISCO (International Stem Cell) Price-to-Free-Cash-Flow : 3.70 (As of Jul. 22, 2025)


View and export this data going back to 2006. Start your Free Trial

What is International Stem Cell Price-to-Free-Cash-Flow?

As of today (2025-07-22), International Stem Cell's share price is $0.1221. International Stem Cell's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 was $0.03. Hence, International Stem Cell's Price-to-Free-Cash-Flow Ratio for today is 3.70.

The historical rank and industry rank for International Stem Cell's Price-to-Free-Cash-Flow or its related term are showing as below:

ISCO' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 0.49   Med: 1.93   Max: 16
Current: 3.7

During the past 13 years, International Stem Cell's highest Price-to-Free-Cash-Flow Ratio was 16.00. The lowest was 0.49. And the median was 1.93.

ISCO's Price-to-Free-Cash-Flow is ranked better than
93.01% of 229 companies
in the Biotechnology industry
Industry Median: 33.93 vs ISCO: 3.70

International Stem Cell's Free Cash Flow per Share for the three months ended in Mar. 2025 was $0.03. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $0.03.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of International Stem Cell was -41.10% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 51.10% per year.

During the past 13 years, International Stem Cell's highest 3-Year average Free Cash Flow per Share Growth Rate was 56.40% per year. The lowest was -24.50% per year. And the median was 27.90% per year.


International Stem Cell Price-to-Free-Cash-Flow Historical Data

The historical data trend for International Stem Cell's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

International Stem Cell Price-to-Free-Cash-Flow Chart

International Stem Cell Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 4.50 0.58 -

International Stem Cell Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.83 - 6.00 - 3.71

Competitive Comparison of International Stem Cell's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, International Stem Cell's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


International Stem Cell's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, International Stem Cell's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where International Stem Cell's Price-to-Free-Cash-Flow falls into.


;
;

International Stem Cell Price-to-Free-Cash-Flow Calculation

International Stem Cell's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.1221/0.033
=3.70

International Stem Cell's Share Price of today is $0.1221.
International Stem Cell's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.03.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

International Stem Cell  (OTCPK:ISCO) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


International Stem Cell Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of International Stem Cell's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


International Stem Cell Business Description

Traded in Other Exchanges
N/A
Address
9745 Businesspark Avenue, San Diego, CA, USA, 92131
International Stem Cell Corp is a clinical-stage biotechnology company. It is focused on therapeutic and biomedical product development with multiple long-term therapeutic opportunities. The company develops different cell types from its stem cells that may result in therapeutic products. The clinical applications of the company include neural stem cells for the treatment of Parkinson's disease and other central nervous system disorders; Liver cells, which are used to treat a variety of congenital and acquired liver diseases; and retinal cells and three-dimensional eye structures. It operates in three segments, the therapeutic market, the biomedical market, and the anti-aging market. The Biomedical products business segment accounts for the majority of revenue.
Executives
Paul V Maier director 3595 JOHN HOPKINS COURT, SAN DIEGO CA 92121
Andrei Semechkin 10 percent owner 1 OVERLOOK DR. UNIT 11, AMHERST NH 03031
Sofya Bakalova officer: Dir. of Legal Affairs & Oper. 5950 PRIESTLY DRIVE, CARLSBAD CA 92008
Wright Don director 2829 RUCKER AVE, 3RD FLOOR, EVERETT WA 98201
Jennifer Stephens officer: Acting Chief Financial Officer 5950 PRIESTLY DRIVE, CARLSBAD CA 92008
Mahnaz Ebrahimi officer: Chief Financial Officer 5950 PRIESTLY DRIVE, CARLSBAD CA 92008
Rouslan Semechkin director, 10 percent owner 2595 JASON CT, OCEANSIDE CA 92056
Tibor Jay Novak officer: Interim CFO 5950 PRIESTLY DRIVE, CARLSBAD CA 92008
John Simon Craw officer: Executive Vice President 5950 PRIESTLY DRIVE, CARLSBAD CA 92008
James H Berglund director C/O INTERNATIONAL STEM CELL CORPORATION, 5950 PRIESTLY DRIVE, CARLSBAD CA 92008
Ar Partners Llc 10 percent owner 5950 PRIESTLY DR., CARLSBAD CA 92008
Kurt Andrew May officer: President and COO 5950 PRIESTLY DRIVE, CARLSBAD CA 92008
Linh T Nguyen officer: Chief Financial Officer 5950 PRIESTLY DR., CARLSBAD CA 92008
Jeffrey Janus director, officer: President 2595 JASON COURT, OCEANSIDE CA 92056
Charles J Casamento director 99 BELBROOK WAY, ATHERTON CA 94027